Multimodality therapy of favorable prognosis non-Hodgkin's lymphoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6345487)

Published in Int J Radiat Oncol Biol Phys on July 01, 1983

Authors

M P Corder, J T Leimert, H H Tewfik, J M Lovett

Articles by these authors

Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol (2000) 4.28

Superficial bladder cancer: progression and recurrence. J Urol (1983) 2.30

Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys (1996) 1.50

Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med (1972) 1.49

Psychological reactions to radiation therapy: reconsideration of the adaptive aspects of anxiety. J Pers Soc Psychol (1985) 1.09

Growth and development of full-term nonasphyxiated small-for-gestational-age newborns: follow-up through adolescence. Pediatrics (1983) 1.08

Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol (1994) 1.07

Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival. Arch Intern Med (1973) 0.99

Plasma cell giant lymph node hyperplasia responding to radiation therapy. AJR Am J Roentgenol (1978) 0.98

A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study. Cancer (1983) 0.94

Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group Study. Cancer (1994) 0.94

Phytohemagglutinin-induced lymphocyte transformation: the relationship to prognosis of Hodgkin's disease. Blood (1972) 0.93

Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer (1978) 0.92

Anxiety and cancer treatment: response to stressful radiotherapy. Health Psychol (1984) 0.91

Myeloid metaplasia and osteolytic lesions. Am J Clin Pathol (1978) 0.88

Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP). Cancer (1982) 0.87

Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant. Cancer Treat Rep (1981) 0.86

Malignant fibrous histiocytoma: a retrospective evaluation of 24 patients. J Surg Oncol (1981) 0.85

Giant lymph node hyperplasia: a review of literature and report of two cases of plasma cell variant responding to radiation therapy. Int J Radiat Oncol Biol Phys (1979) 0.85

Cervical lymph node metastases from an unknown primary. Int J Radiat Oncol Biol Phys (1979) 0.84

Pericardial effusions in patients with malignant diseases. Arch Intern Med (1975) 0.82

DiGeorge syndrome associated with multiple squamous cell carcinomas. Arch Otolaryngol (1977) 0.82

Reversible heart block in acute leukemia. JAMA (1978) 0.81

A financial analysis of Hodgkin lymphoma staging. Am J Public Health (1981) 0.81

ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy. Cancer Treat Rep (1978) 0.81

The influence of ascorbic acid on the growth of solid tumors in mice and on tumor control by X-irradiation. Int J Vitam Nutr Res Suppl (1982) 0.80

Phase II study of cis-dischlorodiammineplatinum(II) in stage IVB Hodgkin's disease. Cancer Treat Rep (1979) 0.80

Effective treatment of metastatic squamous cell carcinoma of the prostate with adriamycin. J Urol (1976) 0.80

Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia. Blood (1980) 0.79

Plasma prostaglandin levels in radiation-induced enteritis. Int J Radiat Oncol Biol Phys (1982) 0.79

Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy. Cancer Treat Rep (1981) 0.78

Cell surface and exopolymer characterization of laboratory stabilized activated sludge from a beverage bottling plant. Water Sci Technol (2001) 0.78

Long-term relapse-free survival in adult acute lymphoblastic leukemia. Cancer Treat Rep (1985) 0.78

Bone marrow chromosome abnormalities in breast cancer in patients following adjuvant chemotherapy. Cancer Res (1980) 0.78

A clinicopathologic study of orbital and adnexal non-Hodgkin's lymphoma. Cancer (1979) 0.78

Bifurcation level of the aorta: landmark for pelvic irradiation. Radiology (1975) 0.78

Para-aortic lymph node irradiation in carcinoma of the cervix after exploratory laparotomy and biopsy-proven positive aortic nodes. Int J Radiat Oncol Biol Phys (1982) 0.77

Marrow neutrophil reserve after adjuvant chemotherapy for carcinoma of the breast. Cancer (1982) 0.76

Use of estrogen receptor data: recommendations for Iowa. J Iowa Med Soc (1980) 0.76

Chordoma: evaluation of clinical behavior and treatment modalities. Int J Radiat Oncol Biol Phys (1978) 0.76

Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study. Urology (1996) 0.76

Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system. Cancer (1976) 0.76

Novel pulsatile cerebrospinal fluid model to assess pressure manometry and fluid sampling through spinal needles of different gauge: support for the use of a 22 G spinal needle with a tapered 27 G pencil-point tip. Br J Anaesth (2011) 0.75

Accuracy of lymphangiography in the diagnosis of paraaortic lymph node metastases from carcinoma of the cervix. Obstet Gynecol (1979) 0.75

An abbreviated phase II trial of thalicarpine. Cancer Treat Rep (1980) 0.75

Monitoring central nervous system methotrexate levels via subcutaneous reservoir. Sources of errors in sampling and their avoidance. Cancer Clin Trials (1980) 0.75

Leucovorin in combination chemotherapy of breast cancer. Clin Pharmacol Ther (1977) 0.75

The use of partially matched, unrelated donors in clinical bone marrow transplantation. Transplantation (1985) 0.75

Death and dying--oncology discussion group. J Psychiatr Nurs Ment Health Serv (1974) 0.75

Changes in patterns of pulmonary perfusions and ventilation after radiation therapy of intrathoracic malignancies. J Iowa Med Soc (1978) 0.75

AIDS in the abstract: teaching AIDS to Iowa nurses. J Contin Educ Health Prof (1989) 0.75

Patient teaching booklet on chemotherapy made flexible through the use of individual drug cards. Oncol Nurs Forum (1978) 0.75

Preparation and administration of chemotherapy. Haematological consequences for hospital-based nurses. Med Toxicol Adverse Drug Exp (1988) 0.75

Phase II study of ICRF-159 in non-Hodgkin's lymphomas. Cancer Treat Rep (1978) 0.75

Metastases to the cavernous sinus from primary carcinoma of the larynx. J Surg Oncol (1986) 0.75

Hodgkin's disease: premature report? Ann Intern Med (1972) 0.75

Sister chromatid exchange analysis in nurses handling antineoplastic drugs. Cancer Invest (1986) 0.75

Marrow transplantation for stable-phase chronic granulocytic leukemia. Exp Hematol (1984) 0.75

Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma. Cancer Invest (1984) 0.75

Cytoarchitecture of Ehrlich ascites carcinoma implanted in the hind limb of ascorbic acid-supplemented mice. Eur J Cancer (1980) 0.75

Granulocyte transfusion therapy: survival directly correlated with bone marrow recovery and the pathogenicity of the infectious organisms. Mil Med (1981) 0.75

Panel discussion: guidelines for planning, conducting, and monitoring clinical studies. Urology (1984) 0.75

Letter: Medical adrenalectomy with aminoglutethimide. JAMA (1975) 0.75

Laetrile. J Iowa Med Soc (1978) 0.75

Familial occurrence of von Willebrand's disease, thrombocytopenia, and severe gastrointestinal bleeding. Am J Med Sci (1973) 0.75

Erythema annulare centrifugum and Hodgkin's disease: association with disease activity. Arch Intern Med (1979) 0.75

Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung. Cancer (1984) 0.75

Letter: The Philadelphia or short Y chromosome. JAMA (1974) 0.75

Possible radiation pericarditis precipitated by actinomycin D. Oncology (1974) 0.75

cis-dichlorodiammineplatinum(II) with and without ICRF-159 in non-Hodgkin's lymphoma. Cancer Treat Rep (1980) 0.75

Salvage therapy of aggressive non-Hodgkin's lymphoma with a combination of vinblastine, bleomycin, and cisplatin. Cancer (1984) 0.75

Comparison of treatments for symptomatic Hodgkin's lymphoma employing decision analysis. Am J Clin Oncol (1984) 0.75

Uterine sarcoma: a retrospective study. J Surg Oncol (1987) 0.75

Failure of leucovorin rescue to prevent reactivation of a solar burn after high dose methotrexate. Cancer (1976) 0.75

Cancer patient care in a general hospital. Mil Med (1975) 0.75

A trial of razoxane (ICRF-159) in patients with prior therapy for Hodgkin's lymphoma. Cancer (1984) 0.75

Total body irradiation and cyclophosphamide, vincristine, prednisone in the treatment of favorable prognosis non-Hodgkin's lymphomas. Int J Radiat Oncol Biol Phys (1979) 0.75

Hepatic scan defects following radiotherapy for lymphoma. Clin Nucl Med (1978) 0.75

Letter: Radiotherapy-induced liver scan defects. J Nucl Med (1976) 0.75

Clinical usefulness and reproducibility of histologic subclassification of advanced diffuse histiocytic lymphoma. Am J Med (1979) 0.75

An unusual manifestation of cryptococcal infection in a chronic lymphedematous arm. Med Pediatr Oncol (1982) 0.75

Decision analysis of estrogen and progesterone receptor testing in the management of breast cancer. Cancer Invest (1987) 0.75

Seminoma metastatic to the jaws. Report of a case. Oral Surg Oral Med Oral Pathol (1975) 0.75

Pulmonary perfusion and ventilation studies in intrathoracic malignancies. J Iowa Med Soc (1977) 0.75

Case report: seminoma testis with an unusual mode of dissemination. J Iowa Med Soc (1976) 0.75

Reasons for failure of MOPP to cure Hodgkin's disease: The importance of dose and schedule. Am J Clin Oncol (1982) 0.75

A decision-analysis methodology for consideration of morbidity factors in clinical decision-making. Am J Clin Oncol (1984) 0.75

Oral contraceptives and reproductive organ cancer risk. J Iowa Med Soc (1982) 0.75

Successful doxorubicin therapy of primary macroglobulinemia resistant to alkylating agents. Am J Hematol (1980) 0.75

Methotrexate with leucovorin rescue in the treatment of gynecologic malignancies. Preliminary report. Oncology (1975) 0.75